The cited cortical-neuron culture study describes N-PEP-12 as a novel, proprietary compound consisting of biopeptides and amino acids. It does not disclose a complete qualitative and quantitative composition or verify the supplied form. We have not matched N-PEP-12 to a current wholesale-list SKU. Before ordering or comparing it, verify the composition, supplied form, manufacturer relationship and identity method. The study does not establish human efficacy, dosing, safety or supplier-batch equivalence.
| Product class | The cited study describes N-PEP-12 as a novel, proprietary compound consisting of biopeptides and amino acids. |
| Composition | Confirm the complete qualitative and quantitative composition for the exact supplied preparation before use. |
| Commercial identity | No exact matching SKU, dosage, form or price exists in the current wholesale price list. |
| Content and purity | A peptide-content or purity percentage is meaningful only with a current method, acceptance criterion and batch result. |
| Comparability | Do not assume equivalence with Cerebrolysin, Memoprove or another preparation without composition, route and manufacturer evidence. |
| Handling | Storage, light protection, reconstitution and stability must come from the exact supplied form and batch documentation. |
Price and SKU not published
No exact matching SKU exists in the current wholesale price list, so no price, dosage, form or quantity tier is published.
The N-PEP-12 name does not identify a sequence, composition, dosage form or manufacturer-equivalent preparation. We cannot issue a product quote until the composition, supplied form and manufacturer-equivalent identity are resolved.
Request the qualitative and quantitative composition, manufacturer, product designation, supplied form and evidence that the quoted material is entitled to use the N-PEP-12 name.
Review the identity method, peptide-content method, acceptance criteria, impurity scope and batch results. Do not substitute a generic area-purity value.
Require correctly identified primary literature and compare the studied preparation, route, dose and population with the proposed research material.
Windisch et al. (2005). N-PEP-12 – a novel peptide compound that protects cortical neurons in culture against different age and disease associated lesions. Journal of Neural Transmission. DOI: 10.1007/s00702-005-0283-7
Study scope: Cortical neurons studied in culture under the experimental conditions reported in the paper. N-PEP-12 described in the abstract as a novel, proprietary compound consisting of biopeptides and amino acids; the complete composition is not disclosed.
What it supports: Supports describing N-PEP-12 as a novel, proprietary compound consisting of biopeptides and amino acids within the cited cortical-neuron culture study.
Boundary: The in-vitro study does not establish a complete composition, human efficacy, dosing, safety or equivalence with a supplier batch.
The cited cortical-neuron culture study describes N-PEP-12 as a novel, proprietary compound consisting of biopeptides and amino acids. A complete composition must still be confirmed for the specific preparation.
No. This page does not publish a complete qualitative or quantitative composition. Confirm it with the manufacturer for the exact preparation.
No. The current wholesale price list has no exact N-PEP-12 match, so no dosage, form, numeric price or availability is shown.
The page uses 10.1007/s00702-005-0283-7 for the bounded compound description and cortical-neuron culture context. 10.3233/JAD-2005-8406 and 10.1007/978-3-7091-6301-6_12 resolve to unrelated publications and are not used as N-PEP-12 evidence.
Do not assume interchangeability. Compare manufacturer, composition, route, dosage form, study material and batch documentation before making that connection.
Request manufacturer and composition evidence, identity and peptide-content methods, impurity and batch results, supplied-form details, handling instructions and correctly matched primary literature.